Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128970) titled 'A Prospective, Randomized, Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Surgical Treatment for Idiopathic Hyperaldosteronism' on July 29.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Beijing Anzhen Hospital, Capital Medical University
Condition:
Idiopathic Hyperaldosteronism, IHA
Intervention:
Surgical group:Patients will undergo surgical treatment.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-01
Target Sample Size: Surgical group:117; Pharmacological group:117;
Countries of Recruitment:
China
To know mo...